Johnson & Johnson
Search results
Developing products for healthier people and planet. Innovating to create formulations that have the power to change the world while protecting the planet. Everyday care is a powerful catalyst in making you feel better, inside and out. Learn about the iconic brands, products, people, and history that make up Kenvue.
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue is the proprietor of well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Mylanta, Neutrogena, Trosyd, Tylenol, and Visine.. Kenvue is headquartered in the Skillman section of Montgomery Township, New Jersey, with plans to ...
Jul 31, 2023 · 8. Kenvue is a publicly traded company on the New York Stock Exchange. In May 2023, Kenvue made our debut as a public company on the New York Stock Exchange, trading under the KVUE ticker symbol. Today, Kenvue is the world’s largest pure-play consumer health company by revenue, with annual sales of ~$15 billion in 2022.
Sep 28, 2022 · NEW BRUNSWICK, N.J. September 28, 2022 — Johnson & Johnson (the “Company”) (NYSE: JNJ) today took another step forward in establishing two independent, market-leading companies with the announcement of Kenvue as the name for the planned New Consumer Health Company.The new corporate brand comes to life through a compelling purpose, and a timeless visual brand.
From gently cleaning tiny fingers during a baby’s first bath to protecting the vitality of your skin to soothing aches and pains — our products deliver safe, effective, everyday care at every stage of life. Kenvue (pronounced ken·view) is inspired by two powerful ideas: “ken,” meaning “knowledge,” an English word primarily used in ...
Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage and propelled forward by science, our iconic brands — including Aveeno ...
May 3, 2023 · Johnson & Johnson’s consumer health business Kenvue priced its IPO at $22 per share Wednesday, toward the high end of its stated range, in an upsized deal that would bring in about $3.8 billion ...
Sep 28, 2022 · “Unveiling the Kenvue brand is a defining moment for our stakeholders and an important part of the planned separation,” said Thibaut Mongon, CEO Designate, Kenvue, the planned New Consumer ...
May 4, 2023 · J&J’s consumer health spinoff Kenvue begins trading at $25.53 per share. Shares of Johnson & Johnson ’s consumer-health spinoff Kenvue jumped 22% Thursday after its market debut on the New ...
Empowered healthcare starts with you. That’s what we believe at Kenvue. We’re the same iconic brands you know and can trust, backed by more than 135 years of research and development, now housed under a dedicated umbrella of continuous innovation. Our top priority is helping you serve your patients and drive better health outcomes.
